Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119959) titled 'Analysis of the clinical characteristics and perioperative risk factors of pheochromocytoma / paraganglioma' on March 6.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Cangzhou Central Hospital
Condition:
Pheochromocytoma
paraganglioma
catecholamine-induced heart disease
hemodynamics
perioperative period
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-06
Target Sample Size: Pheochromocytoma and paraganglioma group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312675
Disclaimer: ...